搜索
OptimizeRx Corp
OPRX添加自选
6.190USD
+0.110+1.81%
收盘 07/02, 13:00（美东）报价延迟15分钟
116.16M总市值
16.76市盈率 TTM
关键数据
6.140今开
6.500最高
519.64K成交量
16.76市盈率 TTM
5.48市盈率动
--股息TTM
2.77%换手率
6.080昨收
6.040最低
2.72M成交额
亏损市盈率静
0.90市净率
0.00%股息率 TTM
4.08%ROA
22.25052周最高
1.24量比
-20.11M净利润
18.77M总股本
0.3693每股收益TTM
1.14Beta
5.56%ROE
4.57052周最低
7.57%振幅
69.89%毛利率
116.16M总市值
5.58回报/风险
4.09%风险率
TradingKey OptimizeRx Corp股票评分
单位: USD 更新时间: 2026-07-01操作建议
OptimizeRx Corp当前公司基本面数据相对非常健康，增长潜力很大。当前估值合理，在软件与IT服务行业排名76/486位。机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价12.40。中期看，股价处于下降通道。近一个月，市场表现很强，技术面和基本面综合得分较高，很强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间，可以做区间波段操作。
OptimizeRx Corp评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
中性
OptimizeRx Corp亮点
亮点风险
OptimizeRx Corporation is a healthcare technology company. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.
业绩高增长
公司营业收入稳步增长，连续3年增长53.00%
业绩转盈
公司业绩转盈，最新年度盈利美元
估值高估
公司最新PE估值16.47，处于3年历史高位
机构减仓
最新机构持股15.47M股，环比减少25.02%
分析师目标
根据
6
位分析师
买入
评级
12.400
目标均价
+128.36%
涨幅空间
OptimizeRx Corp新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
OptimizeRx Corp简介
OptimizeRx Corporation is a healthcare technology company. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.
公司代码OPRX
公司OptimizeRx Corp
CEOSilvestro (Stephen L)
网址https://www.optimizerx.com/
相关品种
热门品种
常见问题
OptimizeRx Corp(OPRX)的当前股价是多少？
OptimizeRx Corp(OPRX)的当前股价是 6.19。
OptimizeRx Corp的股票代码是什么？
OptimizeRx Corp的股票代码是OPRX。
OptimizeRx Corp股票的52周最高点是多少？
OptimizeRx Corp股票的52周最高点是22.25。
OptimizeRx Corp股票的52周最低点是多少？
OptimizeRx Corp股票的52周最低点是4.57。
OptimizeRx Corp的市值是多少？
OptimizeRx Corp的市值是116.16M。
现在OptimizeRx Corp(OPRX)的股票是买入、持有还是卖出？
根据分析师评级，OptimizeRx Corp(OPRX)的总体评级为买入，目标价格为12.40。
OptimizeRx Corp(OPRX)股票的每股收益（EPS TTM）是多少
OptimizeRx Corp(OPRX)股票的每股收益（EPS TTM）是0.28。